AnaBios is Your Source for High-Quality Human Hepatocytes

AnaBios primary human hepatocytes provide the most comprehensive metabolic activity for researchers studying liver function and drug metabolism. Our hepatocytes are carefully isolated and characterized to ensure excellent quality and consistency. AnaBios hepatocytes have demonstrated high viability and functionality, making them an ideal model for predicting drug metabolism and toxicity in humans. 


  • Our tiered qualification process involves multiple stages of testing to ensure superior quality and consistency of hepatocytes across multiple lots.
  • Large hepatocyte lot sizes enable researchers to perform experiments with the same batch of cells for extended periods, reducing experimental variability.
  • Our high cell viability allows for more accurate and reliable prediction of drug metabolism and toxicity in the human liver.
  • Extensive donor information provides researchers with a deeper understanding of the variability in drug metabolism and toxicity responses across different patient populations, enabling the development of more personalized medicine 
  • AnaBios offers fast, reliable shipping for domestic and international orders.


AnaBios Hepatocyte Medium Kit is a specialized solution designed to facilitate the safe and efficient thawing process of cryopreserved hepatocytes.


Ameliorative Effect of Phophodiesterase 4 and 5 Inhibitors in Deoxycorticosterone Acetate-Salt Hypertensive Uni-nephrectomized KKA Mice


Researchers from Takeda Pharamceutical published research that showed PDE4 and PDE5 inhibitors may be promising treatments for diabetic neuropathy with hypertension.

Promoter Methylation Confers Kidney-Specific Expression of the Kothlo Gene


The aging suppressor gene Klotho exhibits kidney-specific expression across species. However, the mechanisms underlying this expression remain poorly understood. This study presents in vitro and in vivo evidence indicating that promoter methylation plays a role in restricting Klotho gene expression.

The CombinedeRole of Galactose-Deficient IgA1 and Streptocaccal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for nephropathy


In this study, IgA nephropathy, characterized by mesangial cell proliferation and immune deposits, the M4 protein from group A streptococcus was found to bind galactose-deficient polymeric IgA1 with high affinity. This binding primarily occurred through the C-terminal region of M4 rather than the IgA-binding region.

Acceptance of Cell Systems cells as documented by placement of an order for Cell Systems products by an authorized representative constitutes knowledge, understanding, and binding acceptance of all binding restrictions on behalf of the recipient institution or enterprise.